Dr Wilding is an internationally recognised expert in the design, development and clinical evaluation of drug delivery systems with over 250 research papers, abstracts and patents. In 2005 he received the Controlled Release Society career achievement award in oral drug delivery and in 2013 became an eminent fellow of the UK Academy of Pharmaceutical Scientists. In 2015, he received an honorary doctorate from Monash University in recognition of his outstanding contribution as a scientific innovator and leader in drug development.

Ian has been a special Professor in the School of Pharmacy at the University of Nottingham since 2001 and in 1997 he was appointed as an expert scientist for the FDA in the area of food effects on drug bioavailability. In a long career commercialising science, Dr Wilding was also the cofounder of Pharmaceutical Profiles (now Quotient Sciences), R5 Pharmaceuticals, Zysis, Modern BioSciences and BioCity Nottingham. Dr Wilding currently consults for over 30 pharmaceutical and biotech companies on a wide range of strategic and technical drug development issues with a particular focus on drug product design and biopharmaceutics.